Antonios Isaac - 10 Apr 2025 Form 4 Insider Report for MANGOCEUTICALS, INC. (MGRX)

Reporting relationship: President, Director
Issuer ticker: MGRX
Reported as of: 10 Apr 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Apr 2025, 17:00:16 UTC
Prior SEC filing: 21 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Antonios Isaac

Key filing fact

Antonios Isaac filed Form 4 for MANGOCEUTICALS, INC. (MGRX) on 11 Apr 2025.

Key facts

This page summarizes Antonios Isaac's Form 4 filing for MANGOCEUTICALS, INC. (MGRX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Apr 2025, 17:00.

Change

Previous filing in this sequence was filed on 21 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MGRX transaction

Common Stock

Award

Transaction value: $0
Shares: +60,000
Change %
Price: $0.000000
Shares after: 60,000
Date: 10 Apr 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Issued as a discretionary bonus in consideration for services rendered as President of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3.